{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:7367"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:7367","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Studies on the pathophysiological mechanism of hypertrophic cardiomyopathy","abstract":"Background Treatment options for patients with symptomatic non-obstructive HCM are limited, driving a need to develop novel treatment strategies. Objectives To investigate the effects of biventricular pacing on symptom status and exercise capacity in patients with symptomatic non-obstructive Hypertrophic Cardiomyopathy and explore the mechanism of benefit. Methods 31 patients with symptomatic, exercise limited non-obstructive Hypertrophic Cardiomyopathy were enrolled into this double blind randomised cross over study of Biventricular vs sham pacing. The primary end point was peak oxygen consumption. Results 29 patients successfully completed the study. Biventricular pacemaker therapy increased peak Oxygen consumption (1.17ml/kg/min) and improved quality of life, without effects on systolic or diastolic mechanical dyssynchrony. A subset of patients in whom left ventricular diastolic volume fell on exercise (n = 15) achieved a greater increase in peak Oxygen consumption vs. those in whom left ventricular diastolic volume increased (1.4 vs. 0.91ml/kg/min p = 0.03) and this was associated with a normalisation of the left ventricular diastolic volume response to exercise. Conclusions Severely symptomatic patients with non-obstructive Hypertrophic Cardiomyopathy may benefit from Biventricular pacing. The mechanism of benefit from this treatment modality was a profound improvement of diastolic filling on exercise potentially due to amelioration of diastolic ventricular interaction.","abstract_html":"Background Treatment options for patients with symptomatic non-obstructive HCM are limited, driving a need to develop novel treatment strategies. Objectives To investigate the effects of biventricular pacing on symptom status and exercise capacity in patients with symptomatic non-obstructive Hypertrophic Cardiomyopathy and explore the mechanism of benefit. Methods 31 patients with symptomatic, exercise limited non-obstructive Hypertrophic Cardiomyopathy were enrolled into this double blind randomised cross over study of Biventricular vs sham pacing. The primary end point was peak oxygen consumption. Results 29 patients successfully completed the study. Biventricular pacemaker therapy increased peak Oxygen consumption (1.17ml/kg/min) and improved quality of life, without effects on systolic or diastolic mechanical dyssynchrony. A subset of patients in whom left ventricular diastolic volume fell on exercise (n = 15) achieved a greater increase in peak Oxygen consumption vs. those in whom left ventricular diastolic volume increased (1.4 vs. 0.91ml/kg/min p = 0.03) and this was associated with a normalisation of the left ventricular diastolic volume response to exercise. Conclusions Severely symptomatic patients with non-obstructive Hypertrophic Cardiomyopathy may benefit from Biventricular pacing. The mechanism of benefit from this treatment modality was a profound improvement of diastolic filling on exercise potentially due to amelioration of diastolic ventricular interaction.","abstract_has_math":false,"creators":["Ahmed, Ibrar"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-07","date_published":"2017-07","updated_at":"2026-11-19T09:29:17Z","subjects":["QH301 Biology","RC Internal medicine"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/7367/2/Ahmed17PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A7367","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["british_heart_foundation"]},{"key":"dc:creator","label":"Author","values":["Ahmed, Ibrar"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2017-07"]},{"key":"dc:date.issued","label":"Date","values":["2017-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Cardiovascular Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/7367/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QH301 Biology","RC Internal medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/7367/2/Ahmed17PhD.pdf","http://etheses.bham.ac.uk//id/eprint/7367/1/Decl_IS_Ahmed17PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Background Treatment options for patients with symptomatic non-obstructive HCM are limited, driving a need to develop novel treatment strategies. Objectives To investigate the effects of biventricular pacing on symptom status and exercise capacity in patients with symptomatic non-obstructive Hypertrophic Cardiomyopathy and explore the mechanism of benefit. Methods 31 patients with symptomatic, exercise limited non-obstructive Hypertrophic Cardiomyopathy were enrolled into this double blind randomised cross over study of Biventricular vs sham pacing. The primary end point was peak oxygen consumption. Results 29 patients successfully completed the study. Biventricular pacemaker therapy increased peak Oxygen consumption (1.17ml/kg/min) and improved quality of life, without effects on systolic or diastolic mechanical dyssynchrony. A subset of patients in whom left ventricular diastolic volume fell on exercise (n = 15) achieved a greater increase in peak Oxygen consumption vs. those in whom left ventricular diastolic volume increased (1.4 vs. 0.91ml/kg/min p = 0.03) and this was associated with a normalisation of the left ventricular diastolic volume response to exercise. Conclusions Severely symptomatic patients with non-obstructive Hypertrophic Cardiomyopathy may benefit from Biventricular pacing. The mechanism of benefit from this treatment modality was a profound improvement of diastolic filling on exercise potentially due to amelioration of diastolic ventricular interaction."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["Studies on the pathophysiological mechanism of hypertrophic cardiomyopathy"]}]}],"canonical_facts":{"dc:contributor.sponsor":["british_heart_foundation"],"dc:creator":["Ahmed, Ibrar"],"dc:date":["2017-07"],"dc:date.issued":["2017-07"],"dc:description.abstract":["Background Treatment options for patients with symptomatic non-obstructive HCM are limited, driving a need to develop novel treatment strategies. Objectives To investigate the effects of biventricular pacing on symptom status and exercise capacity in patients with symptomatic non-obstructive Hypertrophic Cardiomyopathy and explore the mechanism of benefit. Methods 31 patients with symptomatic, exercise limited non-obstructive Hypertrophic Cardiomyopathy were enrolled into this double blind randomised cross over study of Biventricular vs sham pacing. The primary end point was peak oxygen consumption. Results 29 patients successfully completed the study. Biventricular pacemaker therapy increased peak Oxygen consumption (1.17ml/kg/min) and improved quality of life, without effects on systolic or diastolic mechanical dyssynchrony. A subset of patients in whom left ventricular diastolic volume fell on exercise (n = 15) achieved a greater increase in peak Oxygen consumption vs. those in whom left ventricular diastolic volume increased (1.4 vs. 0.91ml/kg/min p = 0.03) and this was associated with a normalisation of the left ventricular diastolic volume response to exercise. Conclusions Severely symptomatic patients with non-obstructive Hypertrophic Cardiomyopathy may benefit from Biventricular pacing. The mechanism of benefit from this treatment modality was a profound improvement of diastolic filling on exercise potentially due to amelioration of diastolic ventricular interaction."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/7367/2/Ahmed17PhD.pdf","http://etheses.bham.ac.uk//id/eprint/7367/1/Decl_IS_Ahmed17PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Cardiovascular Sciences"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/7367/"],"dc:subject":["QH301 Biology","RC Internal medicine"],"dcterms:accessrights":["public","staffonly"],"dc:title":["Studies on the pathophysiological mechanism of hypertrophic cardiomyopathy"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:29:17Z"}